Kadimastem - Stem Cell to Cure Diseases

News & Events > Press Releases

Kadimastem to be included in the TASE Indices

Nov. 27, 2018

Ness Ziona, Israel, November 27, 2018, Israeli biotechnology company Kadimastem (TASE: KDST) received an announcement from the TASE, that it will be included in the TASE Growth Index, the TASE Biomed Index and the TASE Global BlueTech Index. The company will be included in the indices starting December 6, 2018.
The inclusion in the indices is on the basis of the company's meeting TASE requirements relating to market cap and the public's holdings in the company.
Upon inclusion in the indices, the index funds and exchange traded funds are required to hold shares in the company's; this will increase Kadimastem's exposure to institutional investors.


Press Releases Archive